Heplisav-b
Hepatitis B Vaccine (Recombinant) Adjuvanted · Injection, Solution · Intramuscular
No FDA structured label text is available for Heplisav-b. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
Heplisav-b NDC products (3)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 50090-4526 | Hepatitis B Virus Subtype Adw Hbsag Surface Protein Antigen 20 ug/.5mL Injection, Solution | A-S Medication Solutions | BLA |
| 83703-048 | Hepatitis B Virus Subtype Adw Hbsag Surface Protein Antigen 20 ug/.5mL Injection, Solution | Bamboo US BidCo LLC | BLA |
| 43528-003 | Hepatitis B Virus Subtype Adw Hbsag Surface Protein Antigen 20 ug/.5mL Injection, Solution | Dynavax Technologies Corporation | BLA |
Frequently asked questions
Who makes Heplisav-b?
Heplisav-b is listed by 3 labelers in the FDA NDC directory, including A-S Medication Solutions, Bamboo US BidCo LLC, Dynavax Technologies Corporation.